Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
about
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's diseaseBasal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imagingOn the origin of the stronger binding of PIB over thioflavin T to protofibrils of the Alzheimer amyloid-β peptide: a molecular dynamics study.Mild Cognitive Disorders are Associated with Different Patterns of Brain asymmetry than Normal Aging: The PATH through Life Study.Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes.Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsLow plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomographyUsing PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regionsAssociation between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal PathologyThe default mode network and related right hemisphere structures may be the key substrates of dementiaThe ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adultsStriatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients.Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases.Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.Unirhinal Olfactory Testing for the Diagnostic Workup of Mild Cognitive Impairment.Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's DiseasePerfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.The Role of Cerebrovascular Disease in Amyloid Deposition.Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.Different Scales of Cortical Organization are Selectively Targeted in the Progression to Alzheimer's Disease.Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
P2860
Q29619733-A1C41139-972B-47E1-894B-2E5045FE94AEQ30436083-F2FC9D70-4665-45D8-A235-E8D72F5AA127Q30492809-35009395-F1F3-45D4-834D-4E21B2F42E5BQ33402373-E4BE21AD-89FB-4578-AFE4-C23D0473AE0BQ34594635-59D26EA3-6758-43FD-A126-32D09B949815Q34689650-C13C236F-9DDD-47B2-9368-AFBF7E8FAA8FQ34810472-32819134-61E9-4B01-95D7-79DB0BCDC10AQ35032948-BABC380C-B31E-4DB7-9FE0-20301458F17AQ35071184-C3A29434-B4D7-4A95-9905-B13B78A9468AQ35600979-D5C2CC24-9ED6-44EC-923A-284F2EC937AEQ35777166-B742855A-9037-45BF-AEFC-33B27E778144Q35861376-DD1A61EA-78A1-49F9-924B-D3DFD4B5F7C7Q35877929-480D074D-7FD5-496C-9443-948DAABFA3F5Q35940191-DDA3CA4A-18EA-4A58-A3A1-E9855F1D4346Q36178474-96065E8C-7B4D-4962-9524-8FDC50CA95E1Q36484091-B669F922-9BB5-4412-A5B1-36A022B404E6Q36502788-8AB70A6F-E403-4B3E-89BD-85B4F76BBDC6Q36814521-B42C9740-8E27-4E3B-8FD1-555DC8169D25Q37141423-4D8B5EAB-ADD3-44CC-9061-1408006020D1Q37181302-8ADEE6C2-1E4E-4210-85C5-82B583E7E779Q37498339-8A0AE2AA-DBED-4F64-9452-6905687B4BACQ37605374-485E436B-BD8C-4FE7-864C-04D1BC8E5C4DQ37730221-D0A416B5-7F14-4230-BE9F-6E48345FBC2CQ38234645-926B8E1D-E83B-49E0-8D80-510D7B61CB8EQ39223772-5C30F244-BFFD-4356-AC37-C195CA031B3AQ40983810-79D9BA85-8F1D-407F-8C0A-A8817C9F4CEBQ41810067-EC73E51B-C914-4C8D-9BC4-37439D75C5DBQ45817335-AE50305B-412C-49B7-946C-E8CE03896446Q46368284-28B4B29B-97CD-4ADA-A478-B24B030BEE2DQ46716706-21992BE3-5428-4041-A215-4317607C2EC7Q47658024-3E3CD108-056D-444B-81EB-B5D3D40D7EBAQ48342095-F03F4B5C-590D-4F4C-BE71-3AF9285283C1Q48960851-7976F1BB-4E22-42E8-BF98-F11288630561Q48986958-0EBB3105-D13C-4965-BD10-2E2ED88372C8Q50445931-72435920-CD42-4B26-86A1-9B91B3F67CB2Q52142982-630E0151-9F0F-4A84-B8F9-14B2A5470AB3Q52863124-D270E8B7-A669-4B6C-9C02-04CC38865343
P2860
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Characterizing regional correl ...... se with Pittsburgh Compound B.
@ast
Characterizing regional correl ...... se with Pittsburgh Compound B.
@en
type
label
Characterizing regional correl ...... se with Pittsburgh Compound B.
@ast
Characterizing regional correl ...... se with Pittsburgh Compound B.
@en
prefLabel
Characterizing regional correl ...... se with Pittsburgh Compound B.
@ast
Characterizing regional correl ...... se with Pittsburgh Compound B.
@en
P2093
P2860
P50
P1476
Characterizing regional correl ...... ase with Pittsburgh Compound B
@en
P2093
Brian J Lopresti
Chester A Mathis
Cyrus A Raji
Jessica A Hoge
Judith A Saxton
Julie C Price
Nicholas D Tsopelas
Scott K Ziolko
P2860
P304
P356
10.1016/J.JNEUMETH.2008.05.005
P577
2008-05-16T00:00:00Z